文献速递头颈部肿瘤放疗

喉部亚区对患者报告吞咽结局的放射剂量敏感性

Radiation Dose Sensitivity of Subregions of the Larynx to Patient-Reported Swallowing Outcomes.
PubMed 文献 · Adv Radiat Oncol · 2024-02-06

本研究纳入136例接受光子或质子放疗的头颈癌患者,采用EORTC QLQ-H&N35问卷在治疗后1个月内评估患者报告的吞咽评分,分析吞咽功能障碍与喉部5个亚区及全喉剂量学指标的相关性。结果显示会厌是最具预测价值的亚区,会厌最大剂量在单因素(P=0.003)和多因素(P=0.051)分析中均为最显著的剂量学变量。结论支持将会厌纳入标准喉部勾画并在计划评估中关注会厌剂量,数据提示将会厌平均剂量控制在<20至37 Gy、最大剂量控制在<53至60 Gy可减少吞咽困难。

要点

  • 会厌是预测患者报告吞咽评分最具价值的喉部亚区,25个剂量学变量中21个有统计学意义。
  • 会厌最大剂量是单因素(P=0.003)和多因素(P=0.051)分析中最显著的剂量学变量。
  • 单侧与双侧淋巴结照射在单因素(P=0.004)和多因素(P=0.039)分析中均与不良吞咽评分显著相关。

核心结论

  • 会厌对患者报告的生活质量吞咽评分下降的敏感性相对高于喉部其余部分,支持将会厌纳入标准喉部勾画并在计划评估中评估会厌剂量。
  • 数据提示将会厌平均剂量控制在<20至37 Gy、最大剂量控制在<53至60 Gy可减少吞咽困难。

研究设计与样本

  • 队列研究纳入136例头颈癌患者,接受光子或质子放疗,采用EORTC QLQ-H&N35问卷在治疗后1个月内评估患者报告的吞咽评分。
  • 勾画喉部5个亚区及全喉,提取剂量学指标,采用单因素和多因素逻辑回归分析剂量指标与临床变量的统计相关性。
  • 单因素回归模型采用非嵌套模型检验进行统计学比较。

主要发现

  • 单因素分析中,单侧与双侧淋巴结照射(P=0.004)、同步化疗(P=0.007)和手术(P=0.015)是不良吞咽评分的统计学显著预测因素。
  • 多因素分析中,单侧与双侧照射具有统计学显著性(P=0.039)。
  • 会厌是最具预测价值的亚区,25个剂量学变量中多数(21个)被判定为有统计学显著性。
  • 会厌最大剂量是不良吞咽评分在单因素(P=0.003)和多因素(P=0.051)分析中最显著的剂量学变量。
  • 单因素模型比较总体上倾向于会厌相关变量,会厌平均剂量在许多情况下以统计学显著水平被优选。

关键数值与推荐

  • 会厌最大剂量与不良吞咽评分相关:单因素分析P=0.003,多因素分析P=0.051。
  • 单侧与双侧淋巴结照射与不良吞咽评分相关:单因素分析P=0.004,多因素分析P=0.039。
  • 同步化疗(P=0.007)和手术(P=0.015)在单因素分析中与不良吞咽评分相关。
  • 数据提示会厌平均剂量<20至37 Gy、最大剂量<53至60 Gy可减少吞咽困难。

临床怎么用

  • 作者认为应将会厌纳入标准喉部勾画,并在计划评估中评估会厌剂量。
  • 作者的数据提示将会厌平均剂量控制在<20至37 Gy、最大剂量控制在<53至60 Gy可减少吞咽困难。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To assess any correlation between swallowing dysfunction and radiation dose to 5 subregions of the larynx. METHODS AND MATERIALS: A cohort of 136 patients with head and neck cancer, treated with either photon or proton radiation therapy, was assessed using an endpoint of patient-reported swallowing scores, evaluated with the European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire-H&N35 survey, within 1 month after treatment. Five subregions of the larynx were contoured, and dosimetric metrics were extracted for each subregion as well as the total larynx. Univariate and multivariate logistic regression statistical analyses were used to determine statistical correlation with the dose metrics and clinical variables. Univariate regression models were statistically compared using a non-nested model test. RESULTS: Under univariate analysis, unilateral versus bilateral nodal irradiation (P = .004), concurrent chemotherapy (P = .007), and surgery (P = .015) were statistically significant predictors of poor swallowing score. Unilateral versus bilateral irradiation was statistically significant under multivariate analysis (P = .039). The epiglottis was the most predictive subregion of swallowing score, with a majority (21 of 25) of dosimetric variables being identified as statistically significant. The maximum dose to the epiglottis was the most significant dosimetric variable tested for poor swallowing score in both univariate (P = .003) and multivariate (P = .051) analyses. Comparison of univariate models indicated a general preference for epiglottic variables with the mean dose to the epiglottis being preferred at a statistically significant level in many cases. CONCLUSIONS: These results show the relatively increased sensitivity of the epiglottis compared with the rest of the larynx when considering patient-reported decrements in quality-of-life swallowing score and support both the inclusion of the epiglottis in standard larynx contours and the assessment of the epiglottis dose during plan evaluation. Our data suggest that keeping the mean and max doses to the epiglottis <20 to 37 Gy and <53 to 60 Gy, respectively, will reduce swallowing difficulties.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Pepin MD, Anaya S, Garces YI, et al. Radiation Dose Sensitivity of Subregions of the Larynx to Patient-Reported Swallowing Outcomes. Adv Radiat Oncol. 2024. PMID: 38550375. doi:10.1016/j.adro.2024.101458

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。